IGF1 and central nervous system cancer: Exogenous IGF-1 can enhance the invasive and migratory capacity of glioma cells by binding to IGF-1R and has been associated with resistance of gliomas to radiation, chemotherapy, and immunotherapy [25,77,78,79].